{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:43:28Z","timestamp":1761896608860},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jcardioanesthesia.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1053\/j.jvca.2017.08.013","type":"journal-article","created":{"date-parts":[[2017,8,12]],"date-time":"2017-08-12T06:31:42Z","timestamp":1502519502000},"page":"570-575","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pro: Third-Generation Hydroxyethyl Starch Solution Is Safe and Effective for Plasma Volume Expansion During Cardiac Surgery"],"prefix":"10.1053","volume":"32","author":[{"given":"Matthew","family":"McConnell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josh","family":"Baisden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andra E.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2017.08.013_bib1","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1213\/ANE.0000000000000186","article-title":"Intravenous starches: Is suspension the best solution?","volume":"119","author":"Raghunathan","year":"2014","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2017.08.013_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/ALN.0b013e3181a7ec82","article-title":"Hydroxyethyl starches: Different products\u2014different effects","volume":"111","author":"Westphal","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2017.08.013_bib3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1204242","article-title":"Hydroxyethyl starch 130\/0.42 versus Ringer\u2019s acetate in severe sepsis","volume":"367","author":"Perner","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2017.08.013_bib4","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa1209759","article-title":"Hydroxyethyl starch or saline for fluid resuscitation in intensive care","volume":"367","author":"Myburgh","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2017.08.013_bib5","unstructured":"Food and Drug Administration. FDA safety communicaton: Boxed warning on increased mortality and severe renal injury, and additional warning on risk of bleeding, for use of hydroxyethyl starch solutions in some settings. Available at: https:\/\/www.fda.gov\/BiologicsBloodVaccines\/BloodBloodProducts\/ApprovedProducts\/NewDrugApplicationsNDAs\/ucm082785.htm. Accessed June 17, 2017."},{"key":"10.1053\/j.jvca.2017.08.013_bib6","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1097\/ALN.0000000000000021","article-title":"Equivalent efficacy of hydroxyethyl starch 130\/0.4 and human serum albumin: If nothing is the same, is everything different? The importance of context in clinical trials and statistics","volume":"119","author":"Weiskopf","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2017.08.013_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","article-title":"Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, 2012","volume":"39","author":"Dellinger","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.jvca.2017.08.013_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/SHK.0b013e31829727f1","article-title":"Post resusicitation fluid boluses in severe sepsis or septic shock: Prevalence and efficacy (price study)","volume":"40","author":"Bihari","year":"2013","journal-title":"Shock"},{"key":"10.1053\/j.jvca.2017.08.013_bib9","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1213\/ANE.0000000000000221","article-title":"Volume therapy with hydroxyethyl starches: Are we throwing the anesthesia baby out with the intensive care unit bathwater?","volume":"119","author":"Irwin","year":"2014","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2017.08.013_bib10","doi-asserted-by":"crossref","first-page":"f839","DOI":"10.1136\/bmj.f839","article-title":"Hydroxyethyl starch 130\/0.38-0.45 versus crystalloid or albumin in patients with sepsis: Systematic review with meta-analysis and trial sequential analysis","volume":"346","author":"Haase","year":"2013","journal-title":"BMJ"},{"key":"10.1053\/j.jvca.2017.08.013_bib11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00134-013-2863-6","article-title":"Randomised trials of 6% tetrastarch (hydroxyethyl starch 130\/0.4 or 0.42) for severe sepsis reporting mortality: Systematic review and meta-analysis","volume":"39","author":"Patel","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.jvca.2017.08.013_bib12","first-page":"CD000567","article-title":"Colloids versus crystalloids for fluid resuscitation in critically ill patients","author":"Perel","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.jvca.2017.08.013_bib13","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/jama.2013.430","article-title":"Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: A systematic review and meta-analysis","volume":"309","author":"Zarychanski","year":"2013","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2017.08.013_bib14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00134-013-2840-0","article-title":"Fluid resuscitation with 6 % hydroxyethyl starch (130\/0.4 and 130\/0.42) in acutely ill patients: Systematic review of effects on mortality and treatment with renal replacement therapy","volume":"39","author":"Gattas","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.jvca.2017.08.013_bib15","doi-asserted-by":"crossref","first-page":"H1724","DOI":"10.1152\/ajpheart.2000.279.4.H1724","article-title":"Starling forces that oppose filtration after tissue oncotic pressure is increased","volume":"279","author":"Hu","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1053\/j.jvca.2017.08.013_bib16","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1136\/bmj.i1585","article-title":"Sepsis: Pathophysiology and clinical management","volume":"353","author":"Gotts","year":"2016","journal-title":"BMJ"},{"key":"10.1053\/j.jvca.2017.08.013_bib17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/CCM.0b013e3181feeb15","article-title":"Fluid resuscitation in septic shock: A positive fluid balance and elevated central venous pressure are associated with increased mortality","volume":"39","author":"Boyd","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2017.08.013_bib18","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1001\/jama.2013.280502","article-title":"Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: The CRISTAL randomized trial","volume":"310","author":"Annane","year":"2013","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2017.08.013_bib19","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/CCM.0b013e31819cc1a0","article-title":"Pentastarch 10% (250 kDa\/0.45) is an independent risk factor of acute kidney injury following cardiac surgery","volume":"37","author":"Rioux","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2017.08.013_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1213\/ANE.0b013e31827175da","article-title":"Safety of modern starches used during surgery","volume":"116","author":"Van Der Linden","year":"2013","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2017.08.013_bib21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/ALN.0b013e31827e5569","article-title":"Effect of waxy maize-derived hydroxyethyl starch 130\/0.4 on renal function in surgical patients","volume":"118","author":"Martin","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2017.08.013_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/bja\/aet303","article-title":"Incidence of postoperative death and acute kidney injury associated with i.v. 6% hydroxyethyl starch use: Systematic review and meta-analysis","volume":"112","author":"Gillies","year":"2014","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2017.08.013_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11239-007-0187-5","article-title":"Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass","volume":"27","author":"Yavari","year":"2009","journal-title":"J Thromb Thrombolysis"},{"key":"10.1053\/j.jvca.2017.08.013_bib24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jtcvs.2012.04.009","article-title":"Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: A meta-analysis of randomized trials","volume":"144","author":"Navickis","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2017.08.013_bib25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0003-4975(01)02745-X","article-title":"Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: A meta-analysis of postoperative bleeding","volume":"72","author":"Wilkes","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2017.08.013_bib26","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1186\/s13054-014-0656-0","article-title":"The impact of hydroxyethyl starches in cardiac surgery: A meta-analysis","volume":"18","author":"Jacob","year":"2014","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2017.08.013_bib27","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/CCM.0b013e3181958c81","article-title":"Perioperative volume replacement in children undergoing cardiac surgery: Albumin versus hydroxyethyl starch 130\/0.4","volume":"37","author":"Hanart","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2017.08.013_bib28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/EJA.0000000000000328","article-title":"Comparison of hydroxyethyl starch colloids with crystalloids for surgical patients: A systematic review and meta-analysis","volume":"33","author":"Raiman","year":"2016","journal-title":"Eur J Anaesthesiol"},{"key":"10.1053\/j.jvca.2017.08.013_bib29","doi-asserted-by":"crossref","first-page":"428","DOI":"10.5830\/CVJA-2012-026","article-title":"Comparison of the effects of gelatin, Ringer\u2019s solution and a modern hydroxyl ethyl starch solution after coronary artery bypass graft surgery","volume":"23","author":"Alavi","year":"2012","journal-title":"Cardiovasc J Afr"},{"key":"10.1053\/j.jvca.2017.08.013_bib30","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3109\/0886022X.2012.747139","article-title":"The effect of HES (130\/0.4) usage as the priming solution on renal function in children undergoing cardiac surgery","volume":"35","author":"Akkucuk","year":"2013","journal-title":"Ren Fail"},{"key":"10.1053\/j.jvca.2017.08.013_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1749-8090-8-71","article-title":"Hydroxyethyl starch 6%, 130\/0.4 vs. a balanced crystalloid solution in cardiopulmonary bypass priming: A randomized, prospective study","volume":"8","author":"Gurbuz","year":"2013","journal-title":"J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2017.08.013_bib32","first-page":"584","article-title":"Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130\/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass","volume":"76","author":"Choi","year":"2010","journal-title":"Minerva Anestesiol"},{"key":"10.1053\/j.jvca.2017.08.013_bib33","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/CCM.0b013e3181958c81","article-title":"Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130\/0.4","volume":"37","author":"Hanart","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2017.08.013_bib34","first-page":"259","article-title":"Haemodynamics and acid-base equilibrium after cardiac surgery: comparison of rapidly degradable hydroxyethyl starch solutions and albumin","volume":"97","author":"Niemi","year":"2008","journal-title":"Scandinavian Journal of Surgery: SJS: Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society"},{"key":"10.1053\/j.jvca.2017.08.013_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1213\/ane.0b013e31818c1282","article-title":"Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial","volume":"108","author":"Schramko","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2017.08.013_bib36","doi-asserted-by":"crossref","first-page":"428","DOI":"10.5830\/CVJA-2012-026","article-title":"Comparison of the effects of gelatin, Ringer's solution and a modern hydroxyl ethyl starch solution after coronary artery bypass graft surgery","volume":"23","author":"Alavi","year":"2012","journal-title":"Cardiovasc J Afr"},{"key":"10.1053\/j.jvca.2017.08.013_bib37","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/0267659107086656","article-title":"Low molecular starch versus gelatin plasma expander during CPB: does it make a difference?","volume":"22","author":"Boks","year":"2007","journal-title":"Perfusion"},{"key":"10.1053\/j.jvca.2017.08.013_bib38","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/0267659113491446","article-title":"Effect of the colloids gelatin and HES 130\/0.4 on blood coagulation in cardiac surgery patients: a randomized controlled trial","volume":"28","author":"Kimenai","year":"2013","journal-title":"Perfusion"},{"key":"10.1053\/j.jvca.2017.08.013_bib39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1778-428X.2012.01169.x","article-title":"Hydroxyethyl starch 130\/0.4 versus modified succinylated gelatin for volume expansion in pediatric cardiac surgery patients: the effects on perioperative bleeding and transfusion needs","volume":"12","author":"Mulavisala","year":"2012","journal-title":"Transfus Altern Transfus Med"},{"key":"10.1053\/j.jvca.2017.08.013_bib40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/0019-5049.63653","article-title":"Influence of colloid infusion on coagulation during off-pump coronary artery bypass grafting","volume":"54","author":"Muralidhar","year":"2010","journal-title":"Indian J. Anaesth"},{"key":"10.1053\/j.jvca.2017.08.013_bib41","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/0218492309338101","article-title":"Is 6% hydroxyethyl starch 130\/0.4 safe in coronary artery bypass graft surgery?","volume":"17","author":"Ooi","year":"2009","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"10.1053\/j.jvca.2017.08.013_bib42","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/bja\/aeq084","article-title":"Hydroxyethylstarch and gelatin solutions impair blood coagulation after cardiac surgery: a prospective randomized trial","volume":"104","author":"Schramko","year":"2010","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2017.08.013_bib43","unstructured":"Van der Linden PJ, De Hert SG, Deraedt D, et al. Hydroxyethyl starch 130\/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs. Anesth Analg 101:629-634, table of contents, 2005."},{"key":"10.1053\/j.jvca.2017.08.013_bib44","first-page":"91","article-title":"Hydroxyethyl starch 130\/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: the effects on postoperative bleeding and volume expansion needs after elective CABG","volume":"60","author":"Vanhoonacker","year":"2009","journal-title":"Acta Anaesthesiol Belgica"},{"key":"10.1053\/j.jvca.2017.08.013_bib45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0267659107077903","article-title":"Effects of gelatine and medium molecular weight starch as priming fluid in cardiopulmonary bypass--a randomised controlled trial","volume":"22","author":"Yap","year":"2007","journal-title":"Perfusion"},{"key":"10.1053\/j.jvca.2017.08.013_bib46","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3109\/0886022X.2012.747139","article-title":"The effect of HES (130\/0.4) usage as the priming solution on renal function in children undergoing cardiac surgery","volume":"35","author":"Akkucuk","year":"2013","journal-title":"Ren Fail"},{"key":"10.1053\/j.jvca.2017.08.013_bib47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/0971-9784.95072","article-title":"A randomized prospective analysis of alteration of hemostatic function in patients receiving tranexamic acid and hydroxyethyl starch (130\/0.4) undergoing off pump coronary artery bypass surgery","volume":"15","author":"Chakravarthy","year":"2012","journal-title":"Ann Card Anaesth"},{"key":"10.1053\/j.jvca.2017.08.013_bib48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1749-8090-8-71","article-title":"Hydroxyethyl starch 6%, 130\/0.4 vs. a balanced crystalloid solution in cardiopulmonary bypass priming: a randomized, prospective study","volume":"8","author":"Gurbuz","year":"2013","journal-title":"J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2017.08.013_bib49","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1253\/circj.CJ-11-0404","article-title":"Effect of hydroxyethyl starch 130\/0.4 on blood loss and coagulation in patients with recent exposure to dual antiplatelet therapy undergoing off-pump coronary artery bypass graft surgery","volume":"75","author":"Lee","year":"2011","journal-title":"Circ J"},{"key":"10.1053\/j.jvca.2017.08.013_bib50","first-page":"24","article-title":"Effect of colloid versus crystalloid administration of cardiopulmonary bypass prime solution on tissue and organ perfusion","volume":"5","author":"Shahbazi","year":"2011","journal-title":"Int Cardiovasc Res J"},{"key":"10.1053\/j.jvca.2017.08.013_bib51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1749-8090-3-45","article-title":"Hydroxyethyl starch versus Ringer solution in cardiopulmonary bypass prime solutions (a randomized controlled trial)","volume":"3","author":"Tiryakioglu","year":"2008","journal-title":"J Cardiothorac Surg"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105307701730695X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105307701730695X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T11:30:04Z","timestamp":1535455804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105307701730695X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S105307701730695X"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2017.08.013","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pro: Third-Generation Hydroxyethyl Starch Solution Is Safe and Effective for Plasma Volume Expansion During Cardiac Surgery","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2017.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}